Inhba is transcriptionally regulated by Foxa1 through the PI3K/AKT signal pathway in acute lung injury

Y Yuanhua Liu (Department of Electrical and Electronic Engineering) G Guanghui Liu J Jingjing Mei (Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan,) J Jia Li J Jiming Si (Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan,) Y Yan Kang J Jianjun Jin (Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan,)

Abstract

Abstract Acute lung injury (ALI) is a fulminant respiratory failure syndrome with no targeted therapy. We show that Inhba is sharply upregulated in the damaged lung tissue of mice and in BEAS-2B cells, and its abundance tracks with cytokine storm and reactive oxygen species (ROS). Mechanistically, AKT activation is associated with increased FOXA1 phosphorylation and abundance, which transcriptionally induce INHBA; this upregulation of INHBA is a key upstream driver of enhanced ROS production and cytokine release in experimental ALI. Genetic deletion or pharmacologic blockade of PI3K/AKT simultaneously lowered Foxa1 and Inhba, reduced TNF-α, IL-6, and ROS, and improved histologic injury scores and oxygenation. These findings establish the PI3K/AKT–Foxa1–Inhba axis as a central driver in experimental ALI models and support its potential as a druggable target for future investigation. Further validation in human ALI samples will be required to support clinical translation.

Article Details

Volume / Issue Vol. 215, Issue 6
Published June 07, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (7)

Y

Yuanhua Liu

Department of Electrical and Electronic Engineering

G

Guanghui Liu

J

Jingjing Mei

Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan,

J

Jia Li

J

Jiming Si

Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan,

Y

Yan Kang

J

Jianjun Jin

Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University , Zhengzhou, Henan,